Switch to: References

Add citations

You must login to add citations.
  1. Researcher and study participants’ perspectives of consent in clinical studies in four referral hospitals in Vietnam.Jennifer Ilo Van Nuil, Thi Thanh Thuy Nguyen, Thanh Nhan Le Nguyen, Van Vinh Chau Nguyen, Mary Chambers, Thi Dieu Ngan Ta, Laura Merson, Thi Phuong Dung Nguyen, Minh Tu Van Hoang, Michael Parker, Susan Bull & Evelyne Kestelyn - 2020 - BMC Medical Ethics 21 (1):1-12.
    Within the research community, it is generally accepted that consent processes for research should be culturally appropriate and tailored to the context, yet researchers continue to grapple with what valid consent means within specific stakeholder groups. In this study, we explored the consent practices and attitudes regarding essential information required for the consent process within hospital-based trial communities from four referral hospitals in Vietnam. We collected surveys from and conducted semi-structured interviews with study physicians, study nurses, ethics committee members, and (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Informed consent for HIV cure research in South Africa: issues to consider.Ciara Staunton - 2015 - BMC Medical Ethics 16 (1):3.
    South Africa has made great progress in the development of HIV/AIDS testing, treatment and prevention campaigns. Yet, it is clear that prevention and treatment campaigns alone are not enough to bring this epidemic under control.
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  • For-Profit Clinical Trials in Developing Countries—Those Troublesome Patient Benefits.Udo Schuklenk - 2010 - American Journal of Bioethics 10 (6):52-54.
    (2010). For-Profit Clinical Trials in Developing Countries—Those Troublesome Patient Benefits. The American Journal of Bioethics: Vol. 10, No. 6, pp. 52-54.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  • Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials.Rika Moorhouse, Catherine Slack, Michael Quayle, Zaynab Essack & Graham Lindegger - 2014 - BMC Medical Ethics 15 (1):51.
    South Africa is a major hub of HIV prevention trials, with plans for a licensure trial to start in 2015. The appropriate standards of care and of prevention in HIV vaccine trials are complex and debated issues and ethical guidelines offer some direction. However, there has been limited empirical exploration of South African stakeholders’ perspectives on ethical guidance related to prevention and care in HIV vaccine trials.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  • Ensuring Consent to Research is Voluntary: How Far Do We Need to Go?Susan Bull & Graham Charles Lindegger - 2011 - American Journal of Bioethics 11 (8):27-29.
    The American Journal of Bioethics, Volume 11, Issue 8, Page 27-29, August 2011.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  • Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective.Pamela Andanda & Jane Wathuta - 2018 - Medicine, Health Care and Philosophy 21 (1):139-155.
    This paper discusses the need to focus on the dignity of human participants as a legal and ethical basis for providing post-trial access to healthcare. Debate about post-trial benefits has mostly focused on access to products or interventions proven to be effective in clinical trials. However, such access may be modelled on a broad fair benefits framework that emphasises both collateral benefits and interventional products of research, instead of prescribed post-trial access alone. The wording of the current version of the (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations